BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matthay MA, Arabi YM, Siegel ER, Ware LB, Bos LDJ, Sinha P, Beitler JR, Wick KD, Curley MAQ, Constantin JM, Levitt JE, Calfee CS. Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Med 2020;46:2136-52. [PMID: 33206201 DOI: 10.1007/s00134-020-06296-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Arabi YM, Derde LPG, Timsit JF. How COVID-19 will change the management of other respiratory viral infections. Intensive Care Med 2021. [PMID: 34379151 DOI: 10.1007/s00134-021-06491-2] [Reference Citation Analysis]
2 Matthay MA, Liu KD. Preface. Crit Care Clin 2021;37:xiii-xv. [PMID: 34548141 DOI: 10.1016/j.ccc.2021.06.001] [Reference Citation Analysis]
3 Chen Y, Qiu C, Cai W. Identification of key immune genes for sepsis-induced ARDS based on bioinformatics analysis. Bioengineered 2022;13:697-708. [PMID: 34898369 DOI: 10.1080/21655979.2021.2012621] [Reference Citation Analysis]
4 Du M, Garcia JGN, Christie JD, Xin J, Cai G, Meyer NJ, Zhu Z, Yuan Q, Zhang Z, Su L, Shen S, Dong X, Li H, Hutchinson JN, Tejera P, Lin X, Wang M, Chen F, Christiani DC. Integrative omics provide biological and clinical insights into acute respiratory distress syndrome. Intensive Care Med 2021;47:761-71. [PMID: 34032881 DOI: 10.1007/s00134-021-06410-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pham T, de Prost N. Clinical Subphenotypes in Critically Ill Patients With COVID-19: Now Looking for Different Treatment Responses! Chest 2021;160:795-6. [PMID: 34488952 DOI: 10.1016/j.chest.2021.05.042] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Masterson CH, Ceccato A, Artigas A, Dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, Curley GF, Laffey JG. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp 2021;9:61. [PMID: 34970706 DOI: 10.1186/s40635-021-00424-5] [Reference Citation Analysis]
7 Qadir N, Chang SY. Pharmacologic Treatments for Acute Respiratory Distress Syndrome. Crit Care Clin 2021;37:877-93. [PMID: 34548139 DOI: 10.1016/j.ccc.2021.05.009] [Reference Citation Analysis]
8 Wang D, Dai C, Zhang X, Gu C, Liu M, Liu H, Yang F, Wu H, Wang Y. Identification and Functional Analysis of Long Non-coding RNAs in Human Pulmonary Microvascular Endothelial Cells Subjected to Cyclic Stretch. Front Physiol 2021;12:655971. [PMID: 33868024 DOI: 10.3389/fphys.2021.655971] [Reference Citation Analysis]
9 Dunbar H, Weiss DJ, Rolandsson Enes S, Laffey JG, English K. The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing. Cells 2021;10:2982. [PMID: 34831203 DOI: 10.3390/cells10112982] [Reference Citation Analysis]
10 Spinelli E, Mauri T. Why improved PF ratio should not be our target when treating ARDS. Minerva Anestesiol 2021;87:752-4. [PMID: 33688707 DOI: 10.23736/S0375-9393.21.15664-0] [Reference Citation Analysis]
11 Kulkarni HS, Lee JS, Bastarache JA, Kuebler WM, Downey GP, Albaiceta GM, Altemeier WA, Artigas A, Bates JHT, Calfee CS, Dela Cruz CS, Dickson RP, Englert JA, Everitt JI, Fessler MB, Gelman AE, Gowdy KM, Groshong SD, Herold S, Homer RJ, Horowitz JC, Hsia CCW, Kurahashi K, Laubach VE, Looney MR, Lucas R, Mangalmurti NS, Manicone AM, Martin TR, Matalon S, Matthay MA, McAuley DF, McGrath-Morrow SA, Mizgerd JP, Montgomery SA, Moore BB, Noël A, Perlman CE, Reilly JP, Schmidt EP, Skerrett SJ, Suber TL, Summers C, Suratt BT, Takata M, Tuder R, Uhlig S, Witzenrath M, Zemans RL, Matute-Bello G. Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report. Am J Respir Cell Mol Biol 2022;66:e1-e14. [PMID: 35103557 DOI: 10.1165/rcmb.2021-0531ST] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
12 Duggal A, Kast R, Van Ark E, Bulgarelli L, Siuba MT, Osborn J, Rey DA, Zampieri FG, Cavalcanti AB, Maia I, Paisani DM, Laranjeira LN, Serpa Neto A, Deliberato RO. Identification of acute respiratory distress syndrome subphenotypes de novo using routine clinical data: a retrospective analysis of ARDS clinical trials. BMJ Open 2022;12:e053297. [PMID: 34992112 DOI: 10.1136/bmjopen-2021-053297] [Reference Citation Analysis]
13 Ting AE, Baker EK, Champagne J, Desai TJ, dos Santos CC, Heijink IH, Itescu S, Blanc KL, Matthay MA, Mcauley DF, Mcintyre L, Mei SH, Parekkadan B, Rocco PR, Sheridan J, Thébaud B, Weiss DJ. Proceedings of the ISCT scientific signature series symposium, “sdvances in cell and gene therapies for lung diseases and critical illnesses”. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.11.007] [Reference Citation Analysis]
14 Li N, Xiong R, He R, Liu B, Wang B, Geng Q. Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. J Inflamm Res 2021;14:2289-300. [PMID: 34103962 DOI: 10.2147/JIR.S304492] [Reference Citation Analysis]
15 Kuindersma M, Spronk PE. "L'histoire se répète", one size does not fit all. Intensive Care Med 2021. [PMID: 34286360 DOI: 10.1007/s00134-021-06483-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ritter LA, Britton N, Heil EL, Teeter WA, Murthi SB, Chow JH, Ricotta E, Chertow DS, Grazioli A, Levine AR. The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients. J Intensive Care Med 2021;:8850666211032175. [PMID: 34247526 DOI: 10.1177/08850666211032175] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Beitler JR, Thompson BT, Baron RM, Bastarache JA, Denlinger LC, Esserman L, Gong MN, LaVange LM, Lewis RJ, Marshall JC, Martin TR, McAuley DF, Meyer NJ, Moss M, Reineck LA, Rubin E, Schmidt EP, Standiford TJ, Ware LB, Wong HR, Aggarwal NR, Calfee CS. Advancing precision medicine for acute respiratory distress syndrome. Lancet Respir Med 2021:S2213-2600(21)00157-0. [PMID: 34310901 DOI: 10.1016/S2213-2600(21)00157-0] [Reference Citation Analysis]
18 Bihari S, Prakash S, Dixon DL, Cavallaro E, Bersten AD. Induced hypernatremia in patients with moderate-to-severe ARDS: a randomized controlled study. Intensive Care Med Exp 2021;9:33. [PMID: 34219190 DOI: 10.1186/s40635-021-00399-3] [Reference Citation Analysis]
19 Pierrakos C, Smit MR, Pisani L, Paulus F, Schultz MJ, Constantin JM, Chiumello D, Mojoli F, Mongodi S, Bos LDJ. Lung Ultrasound Assessment of Focal and Non-focal Lung Morphology in Patients With Acute Respiratory Distress Syndrome. Front Physiol 2021;12:730857. [PMID: 34594240 DOI: 10.3389/fphys.2021.730857] [Reference Citation Analysis]
20 Wick KD, Leligdowicz A, Zhuo H, Ware LB, Matthay MA. Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS. JCI Insight 2021;6:148983. [PMID: 33974564 DOI: 10.1172/jci.insight.148983] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Gu J, Ran X, Deng J, Zhang A, Peng G, Du J, Wen D, Jiang B, Xia F. Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation. International Immunopharmacology 2022;108:108730. [DOI: 10.1016/j.intimp.2022.108730] [Reference Citation Analysis]
22 Levine AR, Shanholtz CB. I, DOCTOR: The role of machine learning in phenotyping ARDS. EBioMedicine 2021;75:103770. [PMID: 34923201 DOI: 10.1016/j.ebiom.2021.103770] [Reference Citation Analysis]
23 Levine AR, Shanholtz C. A syndrome by any other name: playing the long-term outcome CARDS. Thorax 2022:thoraxjnl-2021-218279. [PMID: 34996849 DOI: 10.1136/thoraxjnl-2021-218279] [Reference Citation Analysis]
24 Blanchard F, Godet T, Pons S, Kapandji N, Jabaudon M, Degos V, Borao L, Bougle A, Monsel A, Futier E, Constantin J, James A. One-year patient outcomes based on lung morphology in acute respiratory distress syndrome: secondary analysis of LIVE trial. Crit Care 2022;26. [DOI: 10.1186/s13054-022-04036-7] [Reference Citation Analysis]
25 Sinha P, Bos LD. Pathophysiology of the Acute Respiratory Distress Syndrome: Insights from Clinical Studies. Crit Care Clin 2021;37:795-815. [PMID: 34548134 DOI: 10.1016/j.ccc.2021.05.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hashem MD, Hopkins RO, Colantuoni E, Dinglas VD, Sinha P, Aronson Friedman L, Morris PE, Jackson JC, Hough CL, Calfee CS, Needham DM. Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial. Thorax 2021:thoraxjnl-2020-216613. [PMID: 34112703 DOI: 10.1136/thoraxjnl-2020-216613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Mantelli F, Allegretti M, Balk RA. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome. Front Pharmacol 2021;12:808797. [PMID: 35095519 DOI: 10.3389/fphar.2021.808797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
28 Zoulikha M, Xiao Q, Boafo GF, Sallam MA, Chen Z, He W. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Acta Pharm Sin B 2022;12:600-20. [PMID: 34401226 DOI: 10.1016/j.apsb.2021.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
29 Schäfer H, Michels IC, Bucher B, Dock-Rust D, Hellstern A. [Weaning from Mechanical Ventilation in Patients with SARS-CoV-2 Infection after Prolonged Mechanical Ventilation - First Experience]. Pneumologie 2021;75:261-7. [PMID: 33873221 DOI: 10.1055/a-1384-8934] [Reference Citation Analysis]
30 Chen J, Xue X, Cai J, Jia L, Sun B, Zhao W. Protective effect of taurine on sepsis‑induced lung injury via inhibiting the p38/MAPK signaling pathway. Mol Med Rep 2021;24:653. [PMID: 34278479 DOI: 10.3892/mmr.2021.12292] [Reference Citation Analysis]
31 Warren A, Camporota L, Ledot S, Scott I, Vuylsteke A. Re: Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs (Friedrichson et al., Critical Care, January 2021). Crit Care 2021;25:123. [PMID: 33771194 DOI: 10.1186/s13054-021-03529-1] [Reference Citation Analysis]
32 Matsumoto S, Traber MG, Leonard SW, Choi J, Fang X, Maishan M, Wick KD, Jones KD, Calfee CS, Gotts JE, Matthay MA. Aerosolized Vitamin E Acetate Causes Oxidative Injury in Mice and in Alveolar Macrophages. Am J Physiol Lung Cell Mol Physiol 2022. [PMID: 35318859 DOI: 10.1152/ajplung.00482.2021] [Reference Citation Analysis]